PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+25.01%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.53B
AUM Growth
+$1.53B
(+23%)
Cap. Flow
+$73.9M
Cap. Flow
% of AUM
4.82%
Top 10 Holdings %
Top 10 Hldgs %
51.28%
Holding
202
New
46
Increased
42
Reduced
36
Closed
32
Top Buys
| 1 |
RXDX
Ignyta, Inc.
RXDX
|
$29.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
$18.4M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$17.9M |
| 4 |
Viatris
VTRS
|
$14.3M |
| 5 |
Heron Therapeutics
HRTX
|
$14M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$21.8M |
| 2 |
BLUE
bluebird bio
BLUE
|
$16.3M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$11.1M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$11M |
| 5 |
uniQure
QURE
|
$10.5M |
Sector Composition
| 1 | Healthcare | 83.91% |
| 2 | Financials | 0.1% |
| 3 | Technology | 0.06% |
| 4 | Consumer Discretionary | 0.06% |
| 5 | Energy | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $204M | 12.3% | 14,439,444 | – | – |
|
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $157M | 9.45% | 3,284,467 -456,800 | -12% | -$21.8M |
|
3
Travere Therapeutics
TVTX
$1.56B
| $91.7M | 5.52% | 2,820,875 +35,895 | +1% | +$1.17M |
|
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $85.5M | 5.15% | 2,809,528 +604,876 | +27% | +$18.4M |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $49.1M | 2.96% | 835,359 -143,000 | -15% | -$8.41M |
|
|
DYAX
6
DELISTED
DYAX CORPORATION
DYAX
| $47.3M | 2.85% | 1,786,315 +9,315 | +0.5% | +$247K |
|
|
NVRO
7
DELISTED
NEVRO CORP.
NVRO
| $42.9M | 2.59% | 798,959 +241,903 | +43% | +$13M |
|
8
Xencor
XNCR
$580M
| $41.4M | 2.49% | 1,884,784 -70,001 | -4% | -$1.54M |
|
|
RLYP
9
DELISTED
RELYPSA INC COM
RLYP
| $37.7M | 2.27% | 1,139,142 -315,000 | -22% | -$10.4M |
|
|
RXDX
10
DELISTED
Ignyta, Inc.
RXDX
| $29.7M | 1.79% | +1,967,600 | New | +$29.7M |
|
11
Talphera
TLPH
$11.1M
| $27.9M | 1.68% | 6,574,060 | – | – |
|
12
Iovance Biotherapeutics
IOVA
$807M
| $25.3M | 1.52% | 2,759,593 +45,044 | +2% | +$413K |
|
|
DSCI
13
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $25M | 1.51% | 348,784 +5,500 | +2% | +$394K |
|
14
ANI Pharmaceuticals
ANIP
$2.03B
| $20.3M | 1.22% | 327,157 +19,373 | +6% | +$1.2M |
|
|
ARAV
15
DELISTED
Aravive, Inc. Common Stock
ARAV
| $20.1M | 1.21% | 1,321,400 -225,071 | -15% | -$3.43M |
|
|
CEMP
16
DELISTED
Cempra, Inc.
CEMP
| $19.7M | 1.18% | 572,500 | – | – |
|
|
PFNX
17
DELISTED
Pfenex Inc.
PFNX
| $19.6M | 1.18% | 1,010,877 +144,454 | +17% | +$2.8M |
|
|
ZSPH
18
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $19M | 1.14% | 361,777 +175,000 | +94% | +$9.17M |
|
|
EGRX
19
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $18.8M | 1.13% | 233,044 +220,956 | +1,828% | +$17.9M |
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $18M | 1.08% | 59,185 +10,000 | +20% | +$3.03M |
|
|
21
uniQure
QURE
$896M
| $17.6M | 1.06% | 650,269 -389,063 | -37% | -$10.5M |
|
22
Acadia Pharmaceuticals
ACAD
$4.38B
| $17.2M | 1.03% | 410,240 -190,000 | -32% | -$7.96M |
|
|
CBPO
23
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $17M | 1.02% | 147,604 +77,604 | +111% | +$8.94M |
|
|
RDUS
24
DELISTED
Radius Health, Inc.
RDUS
| $15.9M | 0.96% | 235,530 +161,530 | +218% | +$10.9M |
|
25
Sonida Senior Living
SNDA
$488M
| $15.7M | 0.94% | 640,500 +35,500 | +6% | +$870K |
|